HPV infection and anal condylomas. Current status in 2006: Description, prevalence and management;Infection HPV et condylomes anaux. État des lieux en 2006: Description, prévalence et prise en charge

Hepato-Gastro

Volumn 13, Issue 3, 2006, Pages 195-205

  Benabderrahmane, Dalila ^a   Abramowitz, Laurent ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

CONDYLOMA; HUMAN; IMMUNITY; POPULATION RESEARCH; PREVALENCE; SHORT SURVEY;

EID: 33744797994     PISSN: 12537020     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (39)

1. Cates N, Hinman A. Sexually transmitted diseases in the 1990s. N Engl J Med 1991; 325: 1368-9.
2. Chardonnet Y, Lizard G, Chignol MC, Schimitt D. Analytical methods for evaluation on whole cells of human papillomavirus infection. Bull Cancer 1995; 82: 107-13.
3. Oriel JD. Natural history of genital warts. Sex Transm Infec 2000; 76: 22-3.
4. Chu QD, Vezeridis MP, Libbey NP, Wanedo HJ. Giant condyloma acuminatum (Buschke-Loewenstein tumor) of the anorectal and perianal regions. Analysis of 42 cases. Dis Colon Rectum 1994; 37: 950-7.
5. Ho GR, Bierman L, Beardsley CJ, Chang SF, Burk RD. Natural history of cervical vaginal papillomavirus infection in young women. N Engl J Med 1998; 338: 423-8.
6. Sobhani I, Walker F, Aparicio T, Abramowitz L, Henin D, Cremieux AC, et al. Effect of anal epidermoïd cancer-related viruses on the dendritic (langherans) cells of the human anal mucosa. Clin Cancer Res 2002; 8: 2862-9.
7. Blauvert A, Clerici M, Lucey DR, Steinberg SM, Yarchoan R, Walker R, et al. Functional studies of epidermal Langherans cells and blood monocytes in HIV infected persons. J Immunol 1995; 154: 3506-15.
8. Franco EL, Villa LL, Sobrinho JP, Prado MC, Rousseau MC, Desy M, et al. Epidemiology of acquisition and clearance of cervical human papillomavirus infection in women from a high-risk area for cervical cancer. Infect Dis 1999; 180: 1415-23.
9. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, et al. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12: 485-90.
10. Frisch M, Glimelius B, Van den Brule AJC. Sexually transmitted infection as a cause of anal cancer. N Engl J Med 1997; 337: 1350-8.
11. Stone KM, Karem KL, Sterberg MR, MacQuillan GM, Poon AD, Linger ER, et al. Seroprevalence of human papillomavirus type 16 infection in the United States. J Infect Dis 2002; 186; 13996-402.
12. Bosch FX, De Sanjose S. Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr 2003; 31: 3-13.
13. Herrero R, Hildesheim A, Bratti C, Sherman ME, Hutchinson M, Morales J, et al. Population-based study of human papillomavirus infection and cervical neoplasia in rural Costa Rica. J Natl Cancer Inst 2000; 92: 464-74.
14. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV negative women. J Infect Dis 2001; 183: 383-91.
15. Franceschi S, Castellsague X, Dal Maso L, Smith JS, Plummer M, Ngelangel C, et al. Prevalence and determinants of human papillomavirus genital infection in men. Br J Cancer 2002; 86: 705-11.
16. Hippelainen M, Syrjanen S, Koskela H, Pulkkinen J, Saarikoski S, Syrjanen K. Prevalence and risk factors of genital human papillomavirus (HPV) infection in healthy males: a study on Finnish conscripts. Sex Transm Dis 1993; 20: 321-8.
17. Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177: 361-7.
18. Bleeker MC, Hogewoning CJ, Van Den Brule AJ, Voorhorst FJ, Van Andel RE, Risse EK, et al. Penile lesions and human papillomavirus inj male sexual partners of women with cervical intraepithelial leneoplasia. J Am Acad Dermatol 2002; 47: 351-7.
19. Critchlow CW, Hawes SE, Kuypers JM, Goldbaum GM, Holmes KK, Surawics CM, et al. Effect of HIV infection on the natural history of anal human papillomavirus infection. AIDS 1998; 12: 1177-84.
20. Piketty C, Darragh TM, Da Costa M, Bruneval P, Heard I, Kazatchkine MD, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138: 453-9.
21. Puy-Montbrun T, Denis J, Ganancia R, Mathonière F, Lemarchand N, Arnous-Dubois N. Anorectal lesions in human immunodeficiency virus-infected patients. Int J Colorectal Dis 1992; 7: 26-30.
22. Abramowitz L, Duval X, Benabderrahmane D, Ravaud P, Walker F, Samson C, et al. Prevalence and risk factors for anal condyloma and anal dysplasia in HIV-infected patients. Gut 2005; 54(suppl VII): A26; (abstract).
23. Frisch M, Goodman MT. Human papillomavirus-associated carcinomas in Hawaii and the mainland US. Cancer 2000; 88: 1464-9.
24. Janet G, Baseman JG, Koutsky LA. The epidemiology of human papillomavirus infection. J Clin Virol 2005; 32: 16-24.
25. Bjorge T, Engeland A, Luostarinen T, Mork J, Gislefoss RE, Jellum E, et al. Human papillomavirus infection as a risk factor for anal and peri-anal skin cancer in a prospective study. Br J Cancer 2002; 87: 61-4.
26. Kubbutat M, Stites DP, Farhat S, Sisler JR, Moss B, Kong F. Role of E6 and E7 oncoproteins in HPV-induced anogenital malignacies. Semin Virol 1996; 7: 295-8.
27. Ryan DP, Compton CC, Mayer RJ. Medical progress; carcinoma of the anal canal. N Engl J Med 2000; 342: 792-800.
28. Palefsky JM. Human papillomavirus infection and anogenital neoplasia in human Immunodeficiency virus-positive men and women. J Natl Cancer Inst Monogr 1998; 23: 15-20.
29. Sobhani I, Vuagnat A, Walker F, Vissuzaine C, Mirin B, Hervatin F, et al. Prevalence of high grade dysplasia and cancer in the anal canal in human papillomavirus-infected individuals. Gastroenterology 2001; 120: 855-66.
30. Sobhani I, Walker A, Roudor-Thoraval F, Abramowitz L, Johanet H, Henin D, et al. Anal carcinoma: incidence of effect of cumulative infections. AIDS 2004; 18: 1561-9.
31. Broker TR, Jin G, Bragg SM. Molecular epidemiology of HPV infections of female genital tract in renal transplant candidates/recipients and HIV-positive patients. In: 17th International Papillomavirus Conference, Charleston, SC, USA, 1999: 15.
32. Harris TG, Kulasingam SL, Kiviat NB, Mao C, Agoff SN, Feng Q, et al. Cigarette smoking, oncogenic human papillomavirus, Ki-67 antigen, and cervical intraepithelial neoplasia. Am J Epidemiol 2004; 9: 834-42.
33. Deacon JM, Evans CD, Yule R, Desai M, Binns W, Taylor C, et al. Sexual behaviour and smoking as determinants of cervical HPV infection and of CIN3 among those infected: a case-control study nested within the Manchester cohort. Br J Cancer 2000; 83: 1565-72.
34. Von Krogh G, Lacey CJ, Gross G, Barrasso R, Schneider A. European course on HPV associated pathology: guidelines for primary care physicians for the diagnosis and management of anogenital warts. Sex Transm Infect 2000; 76: 162-8.
35. Hemmi H, Kaisho T, Takekuchi O. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signalling pathway. Nat Immunol 2002; 3: 196-200.
36. Koutsky LA, Ault KA, Wheeler CM, Brown DR, Barr E, Alvarez FB, et al. A controlled trial of a human papillomavirus type 16 vaccine. N Engl J Med 2002; 347: 1645-51.
37. Villa LL, Costa RL, Petta CA, Andrea RP, Ault KA, Giuliano AR, et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) L1 virus-like particule vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol 2005; 6: 256-7.
38. Harper DM, Franco EL, Wheeler C, Ferris DG, Jenkins D, Schuind A, et al. GlaxoSmithKline HPV Vaccine Study Group. Lancet 2004; 13: 1731-2.
39. Baldwin PJ, van der Burg SH, Boswell CM, Offringa R, Hickling JK, Dobson J, et al. Vaccinia-expressed human papillomavirus 16 and 18 e6 and e7 as a therapeutic vaccination for vulval and vaginal intraepithelial neoplasia. Clin Cancer Res 2003; 9: 5205-13.